Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Humana Bows Out Of Medicare Part D Coverage For Dual Eligibles

Executive Summary

In 2009, Humana will complete its exit from providing Medicare Part D benefits to low-income seniors who qualify for both Medicaid and Medicare coverage

You may also be interested in...



Humana Walmart PDP May Drive Tougher Contracting By Retailers, Drug Plans

The new Medicare prescription drug plan being introduced jointly by Humana and Walmart for 2011 is dramatically less expensive than anything else in the Part D market and seems certain to prompt more intense scrutiny of drug costs among competing retailers and plans.

Humana Walmart PDP May Drive Tougher Contracting By Retailers, Drug Plans

The new Medicare prescription drug plan being introduced jointly by Humana and Walmart for 2011 is dramatically less expensive than anything else in the Part D market and seems certain to prompt more intense scrutiny of drug costs among competing retailers and plans.

Intelligent Assignment Of Part D LIS-Eligibles Could Raise New Challenges

Costs to Medicare related to Part D beneficiaries who receive premium subsidies based on income are mounting, and one solution being discussed is "intelligent assignment" of those beneficiaries to plans. But some members of the Medicare Payment Advisory Committee believe new challenges could arise from implementing such a program

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050097

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel